13:11 21/07/2017 22 Stocks Moving In Friday's Pre-Market Session
22 Stocks Moving In Friday's Pre-Market Session
Benzinga - Jul 21, 2017
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) rose 14.8 percent to $5.20 in pre-market trading after the company disclosed that it has been awarded a $16 million non-dilutive grant from CIRM in support of ALS trial.

15:10 20/07/2017 AEterna Zentaris Inc. (USA) (NASDAQ:AEZS): Another Big Win For Our Readers
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS): Another Big Win For Our Readers
Insider Financial - Jul 20, 2017
At the end of April this year, AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) collapsed from more than $3.35 a share to $0.90 at the start of May.
Maxim Hikes Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA ... - Smarter Analyst
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) Explodes After Macrilen NDA Milestone - StockNewsUnion

23:22 18/07/2017 AEterna Zentaris Inc. (USA) (AEZS) Announces NDA Filing Acceptance By FDA For ...
AEterna Zentaris Inc. (USA) (AEZS) Announces NDA Filing Acceptance By FDA For ...
Smarter Analyst - Jul 18, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has been notified by the U.S. Food and Drug Administration (“FDA”), that the Company's New Drug Application (“NDA”) seeking approval of Macrilen™ (macimorelin) for the evaluation of growth ...
AEterna Zentaris Inc. (USA) (AEZS) Analysts See $-0.41 EPS; Univar (UNVR) SI ... - Herald KS

14:18 30/06/2017 AEterna Zentaris Inc. (USA) (AEZS) Resubmits New Drug Application for Macrilen ...
AEterna Zentaris Inc. (USA) (AEZS) Resubmits New Drug Application for Macrilen ...
Smarter Analyst - Jun 30, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are up nearly 8% in pre-market trading Friday, after the drug maker announced that it has resubmitted a new drug application (NDA) to the FDA, seeking approval of Macrilen™ (macimorelin) for the ...

21:26 08/05/2017 Aeterna Zentaris Inc (USA) (AEZS) Announces Q1:17 Results
Aeterna Zentaris Inc (USA) (AEZS) Announces Q1:17 Results
Smarter Analyst - May 8, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the first quarter ended March 31, 2017.

13:52 01/05/2017 Why AEterna Zentaris Inc. (USA) (AEZS) Shares Collapsed Today
Why AEterna Zentaris Inc. (USA) (AEZS) Shares Collapsed Today
Smarter Analyst - May 1, 2017
Friday turned out to be a nightmare for shareholders of AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), after the drug maker announced that its ZoptEC Phase 3 clinical study of Zoptrex™ (zoptarelin doxorubicin) in women with locally advanced, recurrent or ...
Here's What's Next For AEterna Zentaris Inc (USA)(NASDAQ:AEZS) - Insider Financial
Act On Key Analyst Price Target Shifts: WEIBO CORP (WB), Aeterna Zentaris Inc ... - USA Commerce Daily

14:51 28/04/2017 AEterna Zentaris Inc. (USA) Announces Replacement At the Market Issuance Program
AEterna Zentaris Inc. (USA) Announces Replacement At the Market Issuance Program
Smarter Analyst - Apr 28, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) announced that it has entered into a new At Market Issuance Sales Agreement, dated April 27, 2017, with H.C.

17:25 30/03/2017 AEterna Zentaris Inc. (USA) (AEZS) Macrilen Is Back, Cheers Maxim
AEterna Zentaris Inc. (USA) (AEZS) Macrilen Is Back, Cheers Maxim
Smarter Analyst - Mar 30, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are rising almost 8% today on the heels of indicating it intends to file a new drug application (NDA) for Macrilen (macimorelin), designed to treat adults' growth hormone deficiency (AGHD), by the third ...

21:14 15/03/2017 AEterna Zentaris Inc. (USA) Announces 4Q and Full-Year 2016 Financial Results
AEterna Zentaris Inc. (USA) Announces 4Q and Full-Year 2016 Financial Results
Smarter Analyst - Mar 15, 2017
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) reported financial and operating results for the fourth quarter and year ended December 31, 2016.

20:55 21/12/2009 2.92
2.92
MarketWatch - Dec 21, 2009
Maxim Boosts Price Targets on 2 Biotech Stocks: AEterna Zentaris Inc. (USA) (AEZS), Vertex Pharmaceuticals Incorporated (VRTX).